IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BOLDRINI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 643
EU - Europa 574
NA - Nord America 572
SA - Sud America 70
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 15
OC - Oceania 1
Totale 1.943
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 533
DE - Germania 243
SG - Singapore 191
CN - Cina 171
IT - Italia 154
HK - Hong Kong 84
VN - Vietnam 70
BR - Brasile 60
BD - Bangladesh 52
SE - Svezia 37
FR - Francia 29
RU - Federazione Russa 29
IN - India 28
NL - Olanda 27
CA - Canada 19
FI - Finlandia 16
GB - Regno Unito 13
JP - Giappone 10
TR - Turchia 9
CI - Costa d'Avorio 8
ID - Indonesia 6
KR - Corea 6
AT - Austria 5
PL - Polonia 5
JM - Giamaica 4
PH - Filippine 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
AR - Argentina 3
MX - Messico 3
PK - Pakistan 3
BB - Barbados 2
CH - Svizzera 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
IE - Irlanda 2
MY - Malesia 2
NO - Norvegia 2
RO - Romania 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IQ - Iraq 1
LT - Lituania 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.876
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 223
Dallas 96
Singapore 95
Ashburn 74
Hong Kong 74
Hefei 62
Santa Clara 57
Milan 47
San Jose 42
Los Angeles 25
Council Bluffs 24
Boardman 22
Ho Chi Minh City 20
Hanoi 19
Beijing 17
Bengaluru 17
Rho 14
Munich 13
New York 13
Rome 12
Lauterbourg 11
Tokyo 10
Abidjan 8
Buffalo 8
Da Nang 7
Lappeenranta 7
Naples 7
Jakarta 6
Guangzhou 5
Istanbul 5
Moscow 5
Shanghai 5
Turku 5
Cangzhou 4
Chicago 4
Desio 4
Helsinki 4
Seoul 4
Shenzhen 4
Amsterdam 3
Ankara 3
Atlanta 3
Barnet 3
Cagliari 3
Columbus 3
Elk Grove Village 3
Genoa 3
Haiphong 3
Hải Dương 3
Jackson 3
Jeddah 3
Kingston 3
London 3
Orem 3
Phoenix 3
Pianoro 3
St Louis 3
Toronto 3
Washington 3
Baronissi 2
Belo Horizonte 2
Brooklyn 2
Cambridge 2
Chennai 2
Cleveland 2
Dublin 2
Düsseldorf 2
Ellington 2
Florence 2
Fortaleza 2
Gainesville 2
Go Vap 2
Grand Island 2
Jacksonville 2
Lahore 2
Leesville 2
Lyon 2
Memphis 2
Miano 2
Newark 2
Nuremberg 2
Oslo 2
Poplar 2
Port Saint Lucie 2
Port of Spain 2
Quận Hai 2
Raubach 2
Ribeirão Preto 2
San Francisco 2
San José 2
Scarborough 2
Seregno 2
Silver Spring 2
São Bernardo do Campo 2
São José dos Campos 2
São Paulo 2
Vienna 2
Warsaw 2
Wroclaw 2
Xi'an 2
Totale 1.221
Salva come PNG Salva come JPEG
Nome #
Real-world progression-free survival 2 with CDK4/6 inhibitors plus endocrine therapy and subsequent line: Results from the multicenter SISTER study 247
Risk of thromboembolic events in patients with metastatic solid tumors treated with PARP inhibitors: A systematic review and meta-analysis of phase 3 randomized controlled trials 213
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 208
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer 204
Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives 201
Biomarkers for antibody-drug conjugates in solid tumors 190
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study 150
Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms 147
Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow 144
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials 83
Extendeond Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients 36
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study 29
Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study 18
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment 16
Antibody-drug conjugates in metastatic breast cancer: Sequencing, combinations and resistances 15
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study 15
Fast Mimicking Diets and Other Innovative Nutritional Interventions to Treat Patients with Breast Cancer 11
Venous thromboembolism in pancreatic neuroendocrine neoplasm: a cohort study 9
Pembrolizumab and oral metronomic cyclophosphamide in patients with chest wall breast cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1) 3
null 3
Abstract HER2-02: HER2-02 HER2-Low Status is Associated with Worse Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Patients Treated With First-Line Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy 1
Totale 1.943
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.521
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024195 9 0 5 8 8 9 25 21 9 27 36 38
2024/2025470 28 29 32 60 30 17 14 42 18 50 49 101
2025/20261.094 102 128 173 93 60 41 146 34 65 50 76 126
2026/2027184 91 91 2 0 0 0 0 0 0 0 0 0
Totale 1.943